We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




New Infectious Disease Analytics Platform Speeds Up Clinical Decision-Making at POC

By LabMedica International staff writers
Posted on 03 Jul 2025

During the COVID-19 pandemic, the importance of accurate and timely interpretation of diagnostic data became evident in shaping both public health strategies and clinical outcomes. More...

As the world now grapples with more complex challenges like antimicrobial resistance, viral mutations, and co-infections, turning diagnostic data into actionable insights has become essential for clinical advancement and a key component of global health security. A new infectious disease analytics platform that integrates diagnostic results with advanced statistical modeling is now set to transform how outbreaks are detected, monitored, and addressed.

Seegene (Seoul, South Korea) has launched STAgora, a next-generation real-time infectious disease intelligence system that supports clinical decision-making and enhances pandemic preparedness. STAgora offers real-time visualization of infectious disease patterns across municipal, national, and continental levels, grounded in actual diagnostic test data. It delivers structured diagnostic reports and statistical summaries in a clear and actionable format, complete with customizable dashboards and real-time alert features. Beyond tracking individual cases, the platform also allows users to observe outbreaks in specific local or global regions, enhancing visibility into disease dynamics and enabling timely public health responses based on up-to-date information.

By delivering real-time epidemiological data to national and international health agencies, the platform is poised to strengthen public health decision-making and support the creation of effective response plans for widespread disease outbreaks. STAgora includes over 40 integrated statistical tools that facilitate early identification of unusual pathogen activity and assist in modeling seasonal patterns and emerging outbreaks. These tools cover a wide range of functions, such as monitoring individual infections, analyzing co-infections based on symptoms, and calculating real-time trends in infection rates. Together, they convert static diagnostic information into predictive intelligence that informs proactive healthcare strategies. In contrast to traditional surveillance systems that depend on delayed data, STAgora provides immediate analysis of PCR-derived diagnostics, offering real-time tracking of pathogen spread and AI-powered forecasts of potential outbreaks.

When used alongside Seegene’s proprietary syndromic quantitative PCR technology, STAgora gives a comprehensive view of both single-pathogen and multi-pathogen co-infections. This robust diagnostic perspective allows clinicians to make faster, more precise decisions at the point of care. With STAgora, Seegene aims to build the foundation of a more agile and interconnected global health defense network. The platform’s combination of real-time molecular testing, AI-driven analytics, and global data sharing marks a strategic move toward a smarter public health infrastructure. Seegene envisions STAgora as a core component of the international infectious disease response system, setting a new benchmark in diagnostic intelligence and preparedness.

Related Links:
Seegene


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
PSA Assay
CanAg PSA EIA
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.